摘要:
In the present invention a wireless communication system is disclosed. A base unit communicates with a remote unit. The system comprises means for transmitting, using CDMA, between the base unit and the remote unit, in one of a plurality of frequencies channels selected. In one period of time, the base unit transmits and in another period of time, different from the one period, the remote unit transmits. Further, the system comprises means for changing the one frequency channel selected to another frequency channel, different from the one frequency channel, in response to interference in the one frequency channel. Thus, communication between the base unit and the remote unit is then affected over the another frequency channel.
摘要:
In the present invention a wireless communication system is disclosed. A base unit communicates with a remote unit. The system comprises means for transmitting, using CDMA, between the base unit and the remote unit, in one of a plurality of frequencies channels selected. In one period of time, the base unit transmits and in another period of time, different from the one period, the remote unit transmits. Further, the system comprises means for changing the one frequency channel selected to another frequency channel, different from the one frequency channel, in response to interference in the one frequency channel. Thus, communication between the base unit and the remote unit is then affected over the another frequency channel.
摘要:
In the present invention a method of re-establishing a wireless communication after a communication break is disclosed. Prior to the communication break, a base unit transmits to a remote unit a table of channels of communication to be used. The base unit also transmits a clock signal value to the remote unit. After a communication break, the remote unit continues to count the clock signals generated from a clock signal source internal thereto. The remote unit applies a function to the value of the clock signal to obtain an entry in the table. The channel of communication associated with the entry in the table is selected by the remote unit. The base unit continues to count the clock signals generated internal thereto. The base unit applies the same function as the function used by the remote unit to the value of the clock signal to obtain an entry in the table. The base unit selects the channel of communication associated with the entry in the table. Thereafter, communication is re-established over the channel of communication associated with the entry in the table.
摘要:
A multi-rate wireless communications system that supports a plurality of distributed user terminals in full-duplex simultaneous communications with a central base station, where each user terminal is provided on demand with one of multiple bit rates at a negotiated QOS is provided. Each user is assigned a variable bit rate, a variable processing gain, a variable transmit power and a unique fixed rate spreading code, resulting in a constant bandwidth signal received at a relative power level corresponding to the negotiated QOS. This application can be applied to systems including wireless local loop and mobile cellular. By adjusting signal energy and interference energy, variable bit rates and negotiated QOS parameters can be supported. The forward link between base-station and user terminal, and the reverse link between the user terminal and base-station, can correspond to either a Frequency Division Duplexing (FDD) arrangement where the forward and reverse links occupy different carrier frequencies but overlap in time, or a Time Division Duplexing (TDD) arrangement where the forward and reverse links occupy the same carrier frequency but are in non-overlapping time intervals.
摘要:
A protocol for wireless local area network communication between a base stationary unit and a plurality of wireless terminals is disclosed. The main features of this protocol is based upon channel reservation requests by active wireless terminals. Contention is resolved and authorization is granted with data message signals transmitted by the authorized wireless terminal either immediately for asynchronous service or periodically for a time-based service. The system further provides for the base stationary unit to query the receipt of the data message signal by the wireless terminal authorized to receive the transmission. If no response signal is received, then the base stationary unit would authorize for itself transmission of the data message to relay it, either "over the air" or via wired connection to another base stationary unit in another data cell. The synchronous nature of the method provides for power saving by allowing the receiver and/or transmitter to be powered down during idle and other time slots.
摘要:
In a wireless communication system between a base unit and a remote unit, the base unit transmits periodically a sync signal in a first selected time period in a selected frequency channel. The remote unit scans the frequency channels to detect the sync signal. The remote unit transmits a response signal in the selected frequency channel. The response signal is transmitted in a second selected time period different from the first selected time period. In addition, the remote unit transmits a first control signal encoded by a first code in the selected frequency channel in a third selected time period, different from the first and second selected time periods, containing a set of functional capabilities of the remote unit. The base unit receives and decodes the first control signal to derive the set of functional capabilities of the remote unit and compares it to its own set of functional capabilities to determine a common set of functional capabilities. The base unit transmits a second control signal encoded by the first code in the same selected frequency channel in a fourth selected time period containing the common set of functional capabilities. Thereafter, communication between the base unit and the remote unit is based upon a functional capability selected from the common set.
摘要:
The invention is directed to TRPM8 antagonists of Formula (I). More specifically, the present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and methods for treating TRPM8-mediated disorders. Pharmaceutical and veterinary compositions and methods of treating pain and various other disease states or conditions using compounds of the invention are also described.
摘要:
The invention is directed to compounds of Formula I: wherein A, X, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.
摘要:
The invention is directed to novel vanilloid receptor type 1 (VR1) ligands. More specifically, the invention relates to novel biaryl-derived amides that are potent antagonists or agonists of VR1. Pharmaceutical and veterinary compositions and methods of treating mild to severe pain and various diseases using compounds of the invention are also described.
摘要:
The invention relates to compounds of Formula I: wherein A, X, R2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, colon cancer, stomach cancer, hairy cell leukemia and non-small lung carcinoma; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including arthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.